Skandinaviska Enskilda Banken (SEB)
SRPT icon

Skandinaviska Enskilda Banken (SEB)’s Sarepta Therapeutics SRPT Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,829
Closed -$202K – 906
2022
Q3 		$202K Hold
1,829
– – ﹤0.01% 799
2022
Q2 		$137K Sell
1,829
-295
-14% -$21.7K ﹤0.01% 909
2022
Q1 		$166K Sell
2,124
-265
-11% -$20.3K ﹤0.01% 897
2021
Q4 		$217K Sell
2,389
-777
-25% -$66.4K ﹤0.01% 895
2021
Q3 		$293K Sell
3,166
-346
-10% -$26.7K ﹤0.01% 903
2021
Q2 		$273K Sell
3,512
-11,200
-76% -$849K ﹤0.01% 930
2021
Q1 		$1.1M Buy
14,712
+407
+3% +$37.6K 0.01% 806
2020
Q4 		$2.44M Sell
14,305
-2,072
-13% -$307K 0.02% 575
2020
Q3 		$2.3M Sell
16,377
-1,423
-8% -$216K 0.02% 530
2020
Q2 		$2.85M Buy
17,800
+6,900
+63% +$939K 0.02% 468
2020
Q1 		$1.07M Sell
10,900
-400
-4% -$45.7K 0.01% 639
2019
Q4 		$1.46M Buy
11,300
+6,700
+146% +$676K 0.01% 638
2019
Q3 		$346K Buy
+4,600
New +$543K ﹤0.01% 817

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s SRPT Position: Q4 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Sarepta Therapeutics (SRPT) in Q4 2022, closing a stake of 1,829 shares — an estimated $202K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in SRPT in Q3 2019 and held it in 13 quarters. The position peaked at $2.85M in Q2 2020. 412 funds tracked by Wall St. Rank hold SRPT as of Q4 2022.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Sarepta Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 1,829 Sarepta Therapeutics shares in Q4 2022, an estimated $202K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Sarepta Therapeutics in Q3 2019 and held it in 13 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Sarepta Therapeutics position peaked at $2.85M in Q2 2020.
  • 412 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2022, filed 8 Feb 2023.